You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com | |
Most viewed
- 1. Intrathecal pemetrexed chemotherapy combined with systemic therapy in patients with non-small cell lung cancer and leptomeningeal metastases: a retrospective study
- 2. Mechanistic studies and therapeutic potential of angiopoietin in head and neck tumor angiogenesis
- 3. Clinical Study Shows Modulation of Ki-67 Markers by those taking Avmacol® in Former Smokers at High-risk for Lung Cancer
- 4. The role and research progress of serine metabolism in tumor cells
- 5. Prostate cancer drug now available to more patients with aggressive form of disease
- 6. Test predicts which patients with prostate cancer most likely to develop long-term side effects from radiation therapy
- 7. Editorial: Deciphering the role of signature genes in cancer prognosis and therapy resistance
- 8. Monocyte count combined with GTVnx is an independent prognostic factor in non-metastatic nasopharyngeal carcinoma receiving radiotherapy
- 9. Case Report: FGFR2 inhibitor resistance via PIK3CA and CDKN2A/B in an intrahepatic cholangiocarcinoma patient with FGFR2-SH3GLB1 fusion
- 10. Protocatechualdehyde induced tumor suppressive autophagy through AMPK/ULK1 signaling pathway in gastric cancer
Last updated at 22:16 GMT
Hot News Makers
Health/Pharma Companies
- 45670.55
- 18981.99
- 16727.26
- 13798.98
- 10967.43
- 10329.35
- 8946.45
- 8589.98
- 8551.91
- 8120.25
Drugs, Treatments, Trials
- 10321.93
- 6046.30
- 5640.58
- 5185.25
- 4869.93
- 4713.01
- 4219.53
- 3686.67
- 3298.13
- 3214.01
Last updated at 21:10 GMT
